NCT01980732No Longer Available不适用
68Ga DOTA-TATE PET/CT in the Evaluation of Patients With Somatostatin Receptor Positive Tumors
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- No Longer Available
- 试验地点
- 1
研究概览
简要总结
The primary objective of the study is to evaluate 68Ga-DOTA TATE PET/CT for staging and monitoring response to chemotherapy in patients with carcinoid, neuroendocrine tumors, medullary thyroid cancer and other cancers expressing somatostatin receptors.
研究设计
- 研究类型
- Expanded Access
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Greater than 18 years-old at the time of radiotracer administration
- •Provides written informed consent
- •Known diagnosis of NET or suspected SSTR positive tumors by 111In-Octreotide scan, 18FDG-PET, or MRI of the abdomen when clinically indicated
- •Karnofsky score greater than 50 or ECOG Performance Status 0-2
- •Women of childbearing age must have a negative pregnancy test at screening/baseline
- •Able to remain still for duration of each imaging procedure (about one hour)
排除标准
- •Less than 18 years-old at the time of radiotracer administration
- •Pregnant or nursing
- •Serum creatinine >3.0 mg/dL
- •Hepatic enzyme levels more than 5 times upper limit of normal.
- •Use of any other investigational product or device within 30 days prior to dosing, or known requirement for any other investigational agent prior to completion of all scheduled study assessments.
- •Inability to lie still for the entire imaging time
- •Inability to complete the needed investigational and standard-of-care imaging examinations due to other reasons (severe claustrophobia, radiation phobia, etc.)
- •Any additional medical condition, serious intercurrent illness, or other extenuating circumstance that, in the opinion of the Investigator, may significantly interfere with study compliance.
研究者
Andrei Iagaru
Assistant Professor of Radiology - Nuclear Medicine
Stanford University
研究点 (1)
Loading locations...
相似试验
进行中（未招募）
早期 1 期
An Investigational Scan (68Ga-DOTATATE PET/CT) in Diagnosing Pediatric Metastatic Neuroendocrine TumorsGanglioneuroblastomaGanglioneuromaNeuroblastomaNCT04040088Mayo Clinic20
已完成
不适用
68Ga-DOTATATE PET for Management of Neuroendocrine TumorsNeuroendocrine TumorsNCT03873870University Health Network, Toronto1,916
已完成
1 期
Safety of 68Ga-DOTA-tyr3-Octreotide PET in Diagnosis of Solid TumorsNeuroendocrine TumorsCarcinoid TumorsMedulloblastomaNeuroblastomaNCT01619865Sue O'Dorisio223
招募中
早期 1 期
68Ga-FAPI PET/CT in Patients With Various Fibrotic DiseaseFibrosisPositron-Emission TomographyNCT04831034First Affiliated Hospital of Fujian Medical University500
招募中
3 期
68Ga-DOTA-TATE PET/CT Imaging in NETsNeuroendocrine TumorsNCT04847505Centre de recherche du Centre hospitalier universitaire de Sherbrooke5,000